Thus, there is no clear role for TRT in the prevention or treatment of MCI or dementia. Similarly, another study with a one-year follow-up reviewed the impact of TRT versus placebo in men with MCI and symptomatic hypogonadism and showed no improvement in cognitive function 47, 48. One study showed no difference in cognitive performance in hypogonadal men with mild cognitive impairment on TRT compared to those on placebo at 12 weeks follow-up. This points to a possible link between androgens and amyloid beta pathway and a possible neuroprotective effect through downregulating the amyloid beta toxicity. Additionally, there is an inverse relation between serum or brain testosterone level and hippocampal volume. A randomized, controlled, double-blind trial conducted in 1989 studied the effects of TRT in 40 men with myotonic dystrophy and ultimately demonstrated increased muscle mass but without positive impact on overall strength . Another study found that androgen supplementation led to muscle growth but worsened motor neuron death and survival.
The AR then binds to androgen response elements on androgen target genes to activate or repress their expression 88–90. In addition, a dose–response relationship was observed with the strongest antidepressant effect occurring when men were treated with testosterone doses higher than 500 mg/week . TRT, however, failed to improve cognitive function and increased coronary artery noncalcified plague volume in coronary arteries by 40 mm3/year 15, 70, 71, 73, 74.
This suggests that testosterone and the SNS are closely linked, with testosterone potentially enhancing the body’s "fight or flight" response. There are also evidences against the neuroprotective action of testosterone. Alzheimer's disease (AD), mild cognitive impairment (MCI) or depression. One of the less known testosterone actions is neuroprotection. Testosterone -- the gonadal sex steroid hormone plays an important role in the central nervous system (CNS) development.
D-Aspartic Acid is an amino acid that plays a crucial role in the production and release of hormones in the body. These ingredients work synergistically to support the body’s natural testosterone production. Prime Male, a popular testosterone booster, contains all of these ingredients, along with others like Korean red ginseng, luteolin, and nettle root. These supplements contain ingredients that support the body’s natural testosterone production. The SNS and testosterone are intricately linked, with each influencing the other in a complex interplay. Furthermore, it can inform the use of interventions, such as testosterone boosters, to potentially enhance physical performance and stress resilience.
Basal secretion of LH and FSH, LH pulse frequency, and GnRH-stimulation gonadotropin secretion by the anterior pituitary are not altered in major depressive disorder indicating that anterior pituitary gonadotropin dysregulation may not contribute to low testosterone levels 36, 43, 44. Subsequent neuroendocrine research including meta-analyses  have found that basal testosterone levels and 24-h testosterone secretion are abnormally low in men with major depressive episodes 25, 36, 43. The role of hypothalamic–pituitary–adrenal hypersecretion observed in severe major depressive episodes and the well-known ability of high cortisol to suppress the hypothalamic-pituitary–gonadal axis in the relationship of testosterone and depression requires further investigation. In addition to being a prospective study, another strength of the HIMS study was measuring total testosterone levels using LC–MS/MS mass spectrometry, which is a critical methodology for accurately measuring hypogonadal testosterone levels . This study also reported that low levels of dihydrotestosterone, estradiol, and free testosterone (calculated) did not confer risk for developing incident depression. Further investigation is required to elucidate the role of estradiol and its interaction with testosterone in depression especially in older men with hypogonadal testosterone level, which has been difficult to study due in part to mass spectrometry being necessary for specific, sensitive, and quantitative measurement.
In addition, the roles of dihydrotestosterone, androstenedione, and other androgenic steroids in depression also warrants further investigation. It is also important to note that none of the men in the Rancho Bernardo Study had testosterone levels in the hypogonadal range. Many early cross-sectional studies reported that total testosterone levels in men begin to decline at the age of 40 by a rate of 0.4% per year 15, 16. Regulation of the hypothalamic-pituitary–gonadal axis, testicular synthesis of androgens, and physiological actions of testosterone resulting from androgen receptor signaling in targeted tissues. Future studies should deepen our understanding of TRTs’ effects on MS in men with testosterone deficiency and those with normal levels along with optimizing therapeutic strategies across a broader spectrum of demyelinating diseases.
Androstenedione has moderate androgenic activity, is produced by adrenal glands and gonads, and is derived from DHEA. DHEAS is a weak androgen, produced in the adrenal glands that act as a DHEA reservoir. Testosterone supplementation can have potential adverse events when used at a supratherapeutic level, and prenatal testosterone exposure is believed to contribute to the pathogenesis of neurodevelopmental disease.